Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma

ABSTRACT:

SUBMITTER: Kim D 

PROVIDER: S-EPMC12340269 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature